Mylan Asks Supreme Court To Deny Sanofi's EpiPen Bid
Mylan has urged the U.S. Supreme Court not to take up Sanofi-Aventis' bid to revive an antitrust suit over its failed EpiPen rival, arguing that Sanofi cannot show a product recalled...To view the full article, register now.
Already a subscriber? Click here to view full article